Interestingly, a large-scale computational analysis of tumor-associated CD8 T cell dysfunction also listed TLT-1 as one of the markers associated with CD8 T cell dysfunction in a diverse range of cancers (Jiang et al., 2018), which further supports our findings. This evidence concerns the gene CD8A and neoplasm.